StevenRRouseyMD

PubMed

• 6 citations
  Atrasentan in Patients With Advanced Renal Cell Carcinoma: A Phase 2 Trial of the ECOG-ACRIN Cancer Research Group (E6800).
  Michael A. Carducci, Judith Manola, Suresh G. Nair Md, Glenn Liu, Steven R. Rousey, Janice P. Dutcher, George Wilding> ;Clinical Genitourinary Cancer. 2015 Dec 1
• 27 citations
  A phase II trial of bevacizumab plus temsirolimus in patients with advanced hepatocellular carcinoma.
  Jennifer J. Knox, Rui Qin, Jonathan R. Strosberg, Benjamin R. Tan, Andreas Kaubisch, Anthony B. El-Khoueiry, Tanios Bekaii-Saab, Steven R. Rousey, Helen X. Chen, Charl...> ;Investigational New Drugs. 2015 Feb 1
• 26 citations
  Association of Rash With Outcomes in a Randomized Phase II Trial Evaluating Cetuximab in Combination With Mitoxantrone Plus Prednisone After Docetaxel for Metastatic C...
  Mark D. Fleming, Guru Sonpavde, Michael J. Kolodziej, Sanjay Awasthi, Thomas E. Hutson, Danko Martincic, Ashutosh Rastogi, Steven R. Rousey, Ralph E. Weinstein, Matthe...> ;Clinical Genitourinary Cancer. 2012 Mar 1
• 37 citations
  Azacitidine favorably modulates PSA kinetics correlating with plasma DNA LINE-1 hypomethylation in men with chemonaïve castration-resistant prostate cancer.
  Guru Sonpavde, Ana Aparicio, Feng Zhan, Brittany North, Robert Delaune, Lawrence E. Garbo, Steven R. Rousey, Ralph E. Weinstein, Lianchun Xiao, Kristi A. Boehm, Lina A...> ;Urologic Oncology. 2011 Nov 1
• 33 citations
  Randomized, phase II trial of pemetrexed and carboplatin with or without enzastaurin versus docetaxel and carboplatin as first-line treatment of patients with stage II...
  Mark A. Socinski, Robert N. Raju, Thomas E. Stinchcombe, Darren M. Kocs, Linda S. Couch, David Barrera, Steven R. Rousey, Janak K. Choksi, Robert M. Jotte, Debra A. Pa...> ;Journal of Thoracic Oncology. 2010 Dec 1
• Preliminary results of a randomized phase II trial of pemetrexed (P) + carboplatin (Cb) ± enzastaurin (ENZ) versus docetaxel (D) + Cb as first-line treatment of patien...
  Kocs DM, Raju RN, Socinski MA, Stinchcombe TE, Rousey SR, Barrera D, Wang Y, Bromund J, Treat J, Obasaju CK> ;J. Clin. Oncol.. 2008-05-20
• Azacitidine for castration-resistant prostate cancer progressing on combined androgen blockade.
  Sonpavde G, Aparicio AM, Delaune R, Garbo LE, Rousey SR, Weinstein RE, Williams A, Zhan F, Boehm KA, Asmar L, Von Hoff DD> ;J. Clin. Oncol.. 2008-05-20
• 11 citations
  Phase II trial of docetaxel/capecitabine in hormone-refractory prostate cancer.
  Michael Kolodziej, Marcus A. Neubauer, Steven R. Rousey, Robert E. Pluenneke, George Perrine, Stephanie Mull, Kristi A. Boehm, Des Ilegbodu, Lina Asmar> ;Clinical Genitourinary Cancer. 2006 Sep 1
• 57 citations
  A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocar...
  Jaffer A. Ajani, Yixing Jiang, Josephine Faust, Baochong B. Chang, Linus Ho, James C. Yao, Steven R. Rousey, Shaker Dakhil, Richard C. Cherny, Catherine Craig, Archie ...> ;Investigational New Drugs. 2006 Apr 5
• 15 citations
  A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemia.
  Mark R Litzow, Sandra Lee, John M Bennett, Gordon W Dewald, Robert E Gallagher, Vibha Jain, Elisabeth M Paietta, Janis Racevskis, Steven R Rousey, Joseph J Mazza, Mart...> ;Haematologica. 2006 Aug 1
• 118 citations
  Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation.
  Steven R. Rousey, Susan K. Russler, Mark Gottlieb, Robert C. Ash> ;The American Journal of Medicine. 1991 Nov 1
• 11 citations
  A fatal case of low titer anti-PR cold agglutinin disease.
  Steven R. Rousey, Roy E. Smith> ;American Journal of Hematology. 1990 Dec 1
• Join now to see all